EP 3191186 B1 20210127 - COMPOSITIONS AND METHODS OF USING INTERLEUKIN-4 INDUCED GENE 1 (IL4I1)
Title (en)
COMPOSITIONS AND METHODS OF USING INTERLEUKIN-4 INDUCED GENE 1 (IL4I1)
Title (de)
ZUSAMMENSETZUNGEN UND VERFAHREN ZUR VERWENDUNG VON INTERLEUKIN-4-INDUZIERTEM GEN 1 (IL4I1)
Title (fr)
COMPOSITIONS ET PROCÉDÉS D'UTILISATION DE L'IL4I1 (INTERLEUKINE-4 INDUCED GENE 1)
Publication
Application
Priority
- US 201462048781 P 20140910
- US 2015049196 W 20150909
Abstract (en)
[origin: WO2016040488A2] The invention is directed to methods of promoting myelin formation in central nervous system (CNS) tissue in a subject in need thereof, the method comprising administering to the subject a therapeutically effective amount of interleukin-4 induced gene 1 (IL4-i1) protein. The invention is also directed to methods of monitoring the progression of conditions marked by an impairment of myelin formation in the CNS comprising assessing the levels or activity of IL4-i1 in activated macrophages obtained from the subject.
IPC 8 full level
A61P 25/28 (2006.01); A61K 38/17 (2006.01); A61K 38/43 (2006.01); A61K 38/44 (2006.01); G01N 33/68 (2006.01)
CPC (source: EP US)
A61K 38/1709 (2013.01 - EP US); A61K 38/44 (2013.01 - EP US); A61P 25/28 (2017.12 - EP); C12Q 1/6883 (2013.01 - US); C12Y 104/03002 (2013.01 - EP US); G01N 33/6896 (2013.01 - US); C12Q 2600/158 (2013.01 - US); G01N 2333/906 (2013.01 - US); G01N 2800/285 (2013.01 - US)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
DOCDB simple family (publication)
WO 2016040488 A2 20160317; WO 2016040488 A3 20160901; CA 2960642 A1 20160317; EP 3191186 A2 20170719; EP 3191186 A4 20180425; EP 3191186 B1 20210127; US 2017246259 A1 20170831
DOCDB simple family (application)
US 2015049196 W 20150909; CA 2960642 A 20150909; EP 15840643 A 20150909; US 201515510350 A 20150909